DGCR5 is activated by PAX5 and promotes pancreatic cancer via targeting miR-3163/TOP2A and activating Wnt/β-catenin pathway

por Liu, Shi-lei, Cai, Chen, Yang, Zi-yi, Wu, Zi-you, Wu, Xiang-song, Wang, Xue-feng, Dong, Ping, Gong, Wei
Publicado 2021

Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram

por Wu, Zi-You, Shen, Wei, Yue, Juan-Qing, Yao, Wen-Yan, Liu, Shi-Lei, Jin, Yun-Peng, Dong, Ping, Ma, Fei, Wu, Xiang-Song, Gong, Wei
Publicado 2020

Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer

por Liu, Shi-lei, Liang, Hai-bin, Yang, Zi-yi, Cai, Chen, Wu, Zi-you, Wu, Xiang-song, Dong, Ping, Li, Mao-lan, Zheng, Lei, Gong, Wei
Publicado 2022